Organon & Co. - Common Stock (OGN)

Q1 2025 13F Holders as of 3/31/2025

Type / Class
Equity / Common Stock
Shares outstanding
260M
Number of holders
698
Total 13F shares, excl. options
202M
Shares change
-4.27M
Total reported value, excl. options
$3B
Value change
-$65M
Put/Call ratio
0.75
Number of buys
296
Number of sells
-310
Price
$14.89

Significant Holders of Organon & Co. - Common Stock (OGN) as of Q1 2025

809 filings reported holding OGN - Organon & Co. - Common Stock as of Q1 2025.
Organon & Co. - Common Stock (OGN) has 698 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 202M shares of 260M outstanding shares and own 77.52% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (31.9M shares), VANGUARD GROUP INC (29.7M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (10.7M shares), STATE STREET CORP (8.98M shares), LSV ASSET MANAGEMENT (7.98M shares), MORGAN STANLEY (5.61M shares), SOUND SHORE MANAGEMENT INC /CT/ (4.98M shares), NORDEA INVESTMENT MANAGEMENT AB (4.85M shares), DEPRINCE RACE & ZOLLO INC (4.65M shares), and GEODE CAPITAL MANAGEMENT, LLC (4.52M shares).
This table shows the top 698 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.